Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.16ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.16ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.16EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.16EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CM.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CM.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CM.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CM.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CM.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.11EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.11ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.11ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.2.11EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.11EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.25EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.2.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.25ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.25ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.25EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.25EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.42EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.42ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.42ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.42EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.42EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.42ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.42ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.69EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.69EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BQ.1.1.69ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.69ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-3196.01Germany
BQ.1.1.69EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.69EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
BQ.1.1.69ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.69ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BQ.1.1.70EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.70EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
BQ.1.1.70ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.70ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-2829.42Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used